Pathology, Molecular Diagnostics, Research: Development


Partnering with BioTech Company’s to create Innovative laboratory diagnostics that drive clinical treatment decisions and ultimately assist physicians in effectively treating patients with targeted therapies.

Getting the proper diagnosis earlier can be the difference between life and death. Identifying cancer sooner and with greater sensitivity and specificity is our clear objective. Avero Diagnostics is committed to the research and development of novel assays, and state of the art diagnostic devices that will help physicians make informed treatment decisions and ultimately have a positive impact on patients’ lives.

Our research and development division partners with biotechnology companies and clinicians in their effort to bring new testing devices and targeted biomarkers to clinical utility. To find out how you can be involved in AVERO research and or clinical trials please contact our office at 877-232-9924 or email our research coordinator at

We offer:

  • Years of experience in clinical trials at the academic and commercial level
  • Leaders in Histopathology, Molecular Pathology and Cytopathology
  • Biomarker discovery and evaluation
  • Electronic Data interface for Research Data
  • Clinical Research consulting
  • A network of clinicians eager to support clinical testing
  • CLIA approved and CAP certified